The North America medical compression socks market was valued at USD 327.9 million in 2023 and is anticipated to witness steady growth, with a projected compound annual growth rate (CAGR) of 5.07% from 2024 to 2030. Several key factors are contributing to this positive outlook. Among them are the increasing incidence of chronic venous disorders, advancements in the production and design technologies of compression wear, heightened awareness surrounding the benefits and availability of treatment options, and a steadily growing elderly population. Furthermore, the rapid development of the online retail space and favorable reimbursement policies within the healthcare system are playing a significant role in facilitating greater access to these products, thus fueling the market expansion during the forecast period.

The growing prevalence of chronic venous disorders—including deep vein thrombosis (DVT), varicose veins, and lymphedema—among individuals in the region is a primary driver of demand for medical compression socks. These conditions can lead to discomfort, mobility issues, and other health complications if left untreated. According to data from the Society for Vascular Surgery, nearly 40.0% of adults in the United States are affected by chronic venous insufficiency, underlining the substantial patient base in need of effective management solutions such as compression therapy.

Additionally, the aging demographic in North America is more susceptible to developing venous insufficiency and related conditions, which significantly boosts the demand for medical compression socks. The U.S. Census Bureau projects that the number of Americans aged 65 and above will reach approximately 82.0 million by the year 2050—nearly twice the current elderly population. This demographic trend emphasizes the growing importance of preventive and therapeutic medical products tailored to older adults.

In parallel, rising public awareness about chronic venous disorders and the available treatment options has led to broader acceptance and usage of medical compression socks among patients and healthcare practitioners alike. Awareness initiatives launched by manufacturers and medical organizations play a vital role in encouraging early diagnosis and timely intervention, which in turn enhances patient outcomes and continues to drive the market’s growth trajectory.

Key Market Trends Insights:

• The athletes/sports people segment emerged as the leading category in the North America medical compression socks market, accounting for a significant market share of 33.96% in 2023. This dominance can be attributed to the growing popularity of compression gear among professional and amateur athletes, who increasingly rely on these products to enhance performance and recovery. Notable brands such as CEP and 2XU have carved a niche by specifically designing compression socks tailored for athletes. These specialized socks are engineered to boost blood circulation during physical exertion, minimize muscle fatigue, and support faster post-exercise recovery, making them highly valuable for those engaged in regular or intense physical activity.

• Several broader trends are also influencing the overall market landscape. The presence of stringent regulatory frameworks, coupled with high incidence rates of diabetes and cardiovascular diseases, necessitates the use of medical-grade compression wear in many therapeutic cases. Additionally, there has been a notable cultural shift toward preventive healthcare and wellness, encouraging consumers to adopt products that support long-term health. This shift is amplified by an aging population that is more susceptible to venous and circulatory disorders, further increasing the demand for effective compression solutions.

• Innovation remains a cornerstone of market development, with trade events like Exintex in Mexico providing a platform for showcasing advancements in textile and compression technologies. Such exhibitions highlight the industry’s commitment to product innovation and adaptation to evolving consumer needs, underscoring both the opportunities and unique challenges the market faces.

• Within the region, the U.S. medical compression socks market held the dominant share in 2023, reflecting its large consumer base and well-established healthcare infrastructure. This trend is expected to continue over the forecast period, supported by demographic and health-related factors. The steady rise in the aging population, along with a growing prevalence of chronic conditions such as diabetes and obesity, is propelling the demand for compression socks across various age groups and healthcare settings. These factors collectively contribute to the rapid expansion of the market in the United States.

Order a free sample PDF of the North America Medical Compression Socks Market Intelligence Study, published by Grand View Research.

Market Size Forecast:

• 2023 Market Size: USD 327.9 Million

• 2030 Projected Market Size: USD 460.93 Million

• CAGR (2024-2030): 5.07%

Key Companies Market Share Insights:

Some of the prominent players actively operating in the North America medical compression socks market include SIGVARIS GROUP, Medi, and Mölnlycke Health Care AB. These established companies maintain their competitive edge by implementing a combination of strategic approaches. Innovation remains a core focus, enabling them to continually introduce advanced and effective compression solutions tailored to diverse consumer needs. Additionally, their extensive product portfolios allow them to cater to various medical and athletic requirements, while strong brand recognition reinforces consumer trust and loyalty across the region.

In parallel, emerging companies are making their mark in the industry by identifying underserved market segments and introducing specialized or differentiated products. Many of these newer entrants are leveraging direct-to-consumer business models, particularly through digital platforms and e-commerce channels, allowing them to reach a broader audience more efficiently and cost-effectively. This approach not only enhances their market presence but also helps them build personalized relationships with customers.

Furthermore, both established and emerging players are increasingly engaging in strategic partnerships and collaborations with healthcare professionals, clinics, and medical institutions. These alliances are instrumental in building credibility, expanding distribution networks, and increasing product visibility within clinical settings. By aligning with trusted healthcare stakeholders, companies are better positioned to educate consumers, promote the benefits of compression therapy, and ultimately drive greater adoption of their products.

Key Players

• Julius Zorn, Inc.

• Essity

• SIGVARIS GROUP

• Medi

• Goodhew, LLC

• Cardinal Health

• Medline

• Mölnlycke Health Care AB

• CHARMKING

• Thuasne

• COMRAD

• Enovis (DJO, LLC)

• 3M

• beltwell.com

• Surgical Appliance Industries (SAIBrands)

• Ames Walker

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The North America medical compression socks market is growing steadily, driven by rising cases of venous disorders, an aging population, and increased health awareness. Advancements in product design and materials, along with strong digital and direct-to-consumer strategies, are enhancing market reach. Key players lead through innovation and partnerships, while emerging brands gain traction via online platforms. The market outlook remains positive, with strong potential for continued expansion.